The Future of Gene Therapies in Inherited Retinal Diseases

Mariya Moosajee, MBBS, BSc, PhD, FRCOphth, discussed the next generation of gene therapy for inherited retinal diseases.

Related Videos
Natalie Goedeker, CPNP, on Supporting Gene Therapy’s Ascendance in Muscular Dystrophies
Angela Genge, MD, FRCPC, eMBA, on Targeting STMN2 to Rescue Neurons in ALS
Peter Marks, MD, PhD
Jeffrey S. Chamberlain, PhD
Related Content

ABCA4 Retinopathy Gene Therapy Demonstrates Efficacy in Preclinical Study

March 17th 2023

Around the Helix: Cell and Gene Therapy Company Updates – March 15, 2023

March 15th 2023

LHON Gene Therapy Continues to Show Efficacy and Safety at 3 Years Post-treatment

March 14th 2023

Gene Therapy May Improve Vision in XLRP, Further Research Needed

March 11th 2023

Around the Helix: Cell and Gene Therapy Company Updates – March 8, 2023

March 8th 2023

LHON-ND4 Gene Therapy Trial Completes Enrollment

March 6th 2023

ABCA4 Retinopathy Gene Therapy Demonstrates Efficacy in Preclinical Study

March 17th 2023

Around the Helix: Cell and Gene Therapy Company Updates – March 15, 2023

March 15th 2023

LHON Gene Therapy Continues to Show Efficacy and Safety at 3 Years Post-treatment

March 14th 2023

Gene Therapy May Improve Vision in XLRP, Further Research Needed

March 11th 2023

Around the Helix: Cell and Gene Therapy Company Updates – March 8, 2023

March 8th 2023

LHON-ND4 Gene Therapy Trial Completes Enrollment

March 6th 2023

ABCA4 Retinopathy Gene Therapy Demonstrates Efficacy in Preclinical Study

March 17th 2023

Around the Helix: Cell and Gene Therapy Company Updates – March 15, 2023

March 15th 2023

LHON Gene Therapy Continues to Show Efficacy and Safety at 3 Years Post-treatment

March 14th 2023

Gene Therapy May Improve Vision in XLRP, Further Research Needed

March 11th 2023

Around the Helix: Cell and Gene Therapy Company Updates – March 8, 2023

March 8th 2023

LHON-ND4 Gene Therapy Trial Completes Enrollment

March 6th 2023
© 2023 MJH Life Sciences

All rights reserved.